emtricitabine has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baeten, JM; Balkus, JE; Bukusi, E; Celum, C; Cohen, CR; Donnell, D; Fiedler, T; Fredricks, DN; Heffron, R; Kiarie, J; Lingappa, J; McClelland, RS; Mugo, N; Munch, M | 1 |
| Brenchley, JM; Calantone, N; Carmack, K; DiNapoli, SR; Estes, JD; Gallagher, J; Klase, ZA; Klatt, NR; McCune, JM; Ortiz, AM; Paiardini, M; Perkins, MR; Riddick, NE; Vinton, CL; Vujkovic-Cvijin, I | 1 |
1 trial(s) available for emtricitabine and Disbacteriosis
| Article | Year |
|---|---|
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study.
Topics: Adult; Anti-HIV Agents; Dysbiosis; Emtricitabine; Female; Gardnerella vaginalis; HIV Infections; HIV Seropositivity; HIV-1; Humans; Kenya; Microbiota; Pre-Exposure Prophylaxis; Prospective Studies; Sexual Partners; Tenofovir; Uganda; Vagina; Vaginosis, Bacterial | 2017 |
1 other study(ies) available for emtricitabine and Disbacteriosis
| Article | Year |
|---|---|
IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.
Topics: Animals; Anti-Retroviral Agents; Bacterial Translocation; Cell Proliferation; Combined Modality Therapy; Dysbiosis; Emtricitabine; Gastrointestinal Microbiome; Gastrointestinal Tract; Immunity, Mucosal; Interleukins; Macaca nemestrina; Probiotics; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Th17 Cells | 2016 |